Associations of coffee genetic risk scores with consumption of coffee, tea and other beverages in the UK Biobank

Addiction

Volumn 113, Issue 1, 2018, Pages 148-157

  Taylor, Amy E ^a   Davey Smith, George ^a   Munafò, Marcus R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Caffeine; coffee; drinks; genetics; Mendelian randomization; tea

Indexed keywords

ADULT; AGED; BEVERAGE; BIOBANK; CAUCASIAN; COFFEE; DRINKING BEHAVIOR; GENETIC PREDISPOSITION; GENETICS; HUMAN; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM; TEA; UNITED KINGDOM;

ADULT; AGED; BEVERAGES; BIOLOGICAL SPECIMEN BANKS; COFFEE; DRINKING BEHAVIOR; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TEA; UNITED KINGDOM;

EID: 85030475384     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.13975     Document Type: Article

References (33)

1. Amin N., Byrne E., Johnson J., Chenevix-Trench G., Walter S., Nolte I. M. et al. Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM. Mol Psychiatry 2012; 17: 1116–1129.
2. Cornelis M. C., Monda K. L., Yu K., Paynter N., Azzato E. M., Bennett S. N. et al. Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLOS Genet 2011; 7: e1002033.
3. The C, Caffeine Genetics C, Cornelis M. C., Byrne E. M., Esko T., Nalls M. A. et al. Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry 2014; 20: 647–656.
4. Josse A. R., Da Costa L. A., Campos H., El-Sohemy A. Genetic polymorphisms in AHR and CYP1A2 are associated with habitual caffeine consumption and are modified by age and smoking. FASEB J 2012; 26: no. 1 Supplement 1012.1.
5. Shin S. Y., Fauman E. B., Petersen A. K., Krumsiek J., Santos R., Huang J. et al. An atlas of genetic influences on human blood metabolites. Nat Genet 2014; 46: 543–550.
6. Cornelis M. C., Kacprowski T., Menni C., Gustafsson S., Pivin E., Adamski J. et al. Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior. Hum Mol Genet 2016; 25: 5472–5482.
7. Locke A. E., Kahali B., Berndt S. I., Justice A. E., Pers T. H., Day F. R. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015; 518: 197–206.
8. Furberg H., Kim Y., Dackor J., Boerwinkle E., Franceschini N., Ardissino D. et al. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 2010; 42: 441–447.
9. Treur J. L., Taylor A. E., Ware J. J., Nivard M. G., Neale M. C., McMahon G. et al. Smoking and caffeine consumption: a genetic analysis of their association. Addict Biol 2017; 22: 1090–1102.
10. McMahon G., Taylor A. E., Davey Smith G., Munafo M. R. Phenotype refinement strengthens the association of AHR and CYP1A1 genotype with caffeine consumption. PLOS ONE 2014; 9: e103448.
11. Davey Smith G., Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014; 23: R89–R98.
12. Davey Smith G., Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 2003; 32: 1–22.
13. Minica C., Dolan C. V., Boomsma D. I., Geus E. J., Neale M. C. Extending causality tests with genetic instruments: an integration of Mendelian randomization and the classical twin design. Bioarchive 2017; https://doi.org/10.1101/134585.
14. Bowden J., Davey S. G., Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015; 44: 512–525.
15. Daly J. W., Fredholm B. B. Caffeine—an atypical drug of dependence. Drug Alcohol Depend 1998; 51: 199–206.
16. Huxley R., Lee C. M., Barzi F., Timmermeister L., Czernichow S., Perkovic V. et al. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Arch Intern Med 2009; 169: 2053–2063.
17. O'Keefe J. H., Bhatti S. K., Patil H. R., Dinicolantonio J. J., Lucan S. C., Lavie C. J. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. J Am Coll Cardiol 2013; 62: 1043–1051.
18. Lucas M., Mirzaei F., Pan A., Okereke O. I., Willett W. C., O'Reilly E. J. et al. Coffee, caffeine, and risk of depression among women. Arch Intern Med 2011; 171: 1571–1578.
19. Ding M., Satija A., Bhupathiraju S. N., Hu Y., Sun Q., Han J. et al. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation 2015; 132: 2305–2315.
20. Nordestgaard A. T., Thomsen M., Nordestgaard B. G. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. Int J Epidemiol 2015; 44: 551–565.
21. Kwok M. K., Leung G. M., Schooling C. M. Habitual coffee consumption and risk of type 2 diabetes, ischemic heart disease, depression and Alzheimer's disease: a Mendelian randomization study. Sci Rep 2016; 6: 36500.
22. Taylor A. E., Martin R. M., Geybels M. S., Stanford J. L., Shui I., Eeles R. et al. Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. Int J Cancer 2017; 140: 322–328.
23. Collins R. What makes UK Biobank special? Lancet 2012; 379: 1173–1174.
24. Liu B., Young H., Crowe F. L., Benson V. S., Spencer E. A., Key T. J. et al. Development and evaluation of the Oxford WebQ, a low-cost, web-based method for assessment of previous 24 h dietary intakes in large-scale prospective studies. Public Health Nutr 2011; 14: 1998–2005.
25. Bowden J., Davey Smith G., Haycock P. C., Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40: 304–314.
26. Benowitz N. L., Peng M., Jacob P. III. Effects of cigarette smoking and carbon monoxide on chlorzoxazone and caffeine metabolism. Clin Pharmacol Ther 2003; 74: 468–474.
27. Wain L. V., Shrine N., Miller S., Jackson V. E., Ntalla I., Artigas M. S. et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir Med 2015; 3: 769–781.
28. Anzenbacher P., Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 2001; 58: 737–747.
29. Treur J. L., Taylor A. E., Ware J. J., McMahon G., Hottenga J. J., Baselmans B. M. et al. Associations between smoking and caffeine consumption in two European cohorts. Addiction 2016; 111: 1059–1068.
30. Clarke T.-K., Adams M. J., Davies G., Howard D. M., Hall L. S., Padmanabhan S. et al. Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N=112,117). Mol Psychiatry 2017; https://doi.org.10.1038/mp.2017.153.
31. Glymour M. M., Tchetgen E. J., Robins J. M. Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions. Am J Epidemiol 2012; 175: 332–339.
32. Cole S. R., Platt R. W., Schisterman E. F., Chu H., Westreich D., Richardson D. et al. Illustrating bias due to conditioning on a collider. Int J Epidemiol 2010; 39: 417–420.
33. Munafo M., Tilling K., Taylor A. E., Evans D. M., Davey Smith G. Collider scope: how selection bias can induce spurious associations. bioRxiv 2016; https://doi.org/10.1101/079707.